Is Cosmo Pharmaceuticals NV stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Cosmo Pharmaceuticals NV pays dividends. Last time was Friday 12th of July 2024 where the investors holding the stock on Wednesday 10th of July 2024 were paid CHF1.94713 per share. Over the last 8 times between 2014 and 2024, Cosmo Pharmaceuticals NV has paid CHF11.23152 with an average of CHF1.4 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Cosmo Pharmaceuticals NV 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was CHF83.00, you would have made a loss of CHF-5.30 per share or -6.39%
Yes, the average daily trading liquidity for Cosmo Pharmaceuticals NV is CHF14 731 thousand. You should therefore be able to get in and out of your positions relatively fast.
Cosmo Pharmaceuticals NV has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 18.28, the company's ability to pay off the debt is good. The company has a very low net profit margin of 1.19%, which is challenging.
We have calculated the inflation risk for Cosmo Pharmaceuticals NV to be low [0.2 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.